Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study).
Hamburger JN, Serruys PW, Scabra-Gomes R, Simon R, Koolen JJ, Fleck E, Mathey D, Sievert H, Rutsch W, Buchwald A, Marco J, Al-Kasab SM, Pizulli L, Hamm C, Corcos T, Reifart N, Hanrath P, Taeymans Y. Hamburger JN, et al. Among authors: koolen jj. Am J Cardiol. 1997 Dec 1;80(11):1419-23. doi: 10.1016/s0002-9149(97)00704-2. Am J Cardiol. 1997. PMID: 9399714 Free article. Clinical Trial.
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial.
Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R; PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Erbel R, et al. Among authors: koolen j. Lancet. 2007 Jun 2;369(9576):1869-1875. doi: 10.1016/S0140-6736(07)60853-8. Lancet. 2007. PMID: 17544767 Clinical Trial.
Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
Gutiérrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E, Serruys PW. Gutiérrez-Chico JL, et al. Among authors: koolen jj. EuroIntervention. 2011 Oct 30;7(6):711-22. doi: 10.4244/EIJV7I6A114. EuroIntervention. 2011. PMID: 21986329 Free article. Clinical Trial.
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
Gomez-Lara J, Diletti R, Brugaletta S, Onuma Y, Farooq V, Thuesen L, McClean D, Koolen J, Ormiston JA, Windecker S, Whitbourn R, Dudek D, Dorange C, Veldhof S, Rapoza R, Regar E, Garcia-Garcia HM, Serruys PW. Gomez-Lara J, et al. Among authors: koolen j. EuroIntervention. 2012 Jun 20;8(2):214-24. doi: 10.4244/EIJV8I2A35. EuroIntervention. 2012. PMID: 22030265
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
Brugaletta S, Gomez-Lara J, Bruining N, Radu MD, van Geuns RJ, Thuesen L, McClean D, Koolen J, Windecker S, Whitbourn R, Oberhauser J, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW. Brugaletta S, et al. Among authors: koolen j. EuroIntervention. 2012 Jul 20;8(3):352-8. doi: 10.4244/EIJV8I3A54. EuroIntervention. 2012. PMID: 22130182 Free article.
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials.
Gogas BD, Bourantas CV, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns RJ, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston JA, Serruys PW. Gogas BD, et al. Among authors: koolen j. EuroIntervention. 2013 Oct;9(6):709-20. doi: 10.4244/EIJV9I6A115. EuroIntervention. 2013. PMID: 23628499 Free article.
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Ormiston JA. Serruys PW, et al. Among authors: koolen j. EuroIntervention. 2014 Mar 20;9(11):1271-84. doi: 10.4244/EIJV9I11A217. EuroIntervention. 2014. PMID: 24291783 Free article. Clinical Trial.
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI.
Brener SJ, Dambrink JH, Maehara A, Chowdhary S, Gershlick AH, Genereux P, Koolen J, Mehran R, Fahy M, Gibson CM, Stone GW. Brener SJ, et al. Among authors: koolen j. EuroIntervention. 2014 Feb;9(10):1195-201. doi: 10.4244/EIJV9I10A201. EuroIntervention. 2014. PMID: 24561570 Free article. Clinical Trial.
188 results